HI
SNTI icon

Harbour Investments’s Senti Biosciences Holdings SNTI Stock Holding History

Harbour Investments’s Portfolio SNTI Stock Details SNTI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-1,500
Closed -$3.39K – 3573
2024
Q3 		$3.39K Buy
+1,500
New +$3.96K ﹤0.01% 2759
2024
Q2 		– Sell
-1,500
Closed -$5.66K – 3365
2024
Q1 		$5.66K Hold
1,500
– – ﹤0.01% 2448
2023
Q4 		$9.9K Buy
1,500
+500
+50% +$1.95K ﹤0.01% 2147
2023
Q3 		$4.13K Hold
1,000
– – ﹤0.01% 2339
2023
Q2 		$6.27K Buy
1,000
+800
+400% +$7.81K ﹤0.01% 2207
2023
Q1 		$2.36K Hold
200
– – ﹤0.01% 2516
2022
Q4 		$2.82K Buy
+200
New +$4.88K ﹤0.01% 2427

Other funds holding SNTI

NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
8GI
8VC GP I Austin, Texas $39.6M AUM 36.39% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
VF
Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return

Harbour Investments's SNTI Position: Q4 2024 in Review

Harbour Investments sold out of Senti Biosciences Holdings (SNTI) in Q4 2024, closing a stake of 1,500 shares — an estimated $3.39K sold.

Harbour Investments first reported a position in SNTI in Q4 2022 and held it in 7 quarters. The position peaked at $9.9K in Q4 2023. 16 funds tracked by Wall St. Rank hold SNTI as of Q4 2024.

  • Harbour Investments reported no remaining Senti Biosciences Holdings position as of Q4 2024 after selling out during the quarter.
  • Harbour Investments sold 1,500 Senti Biosciences Holdings shares in Q4 2024, an estimated $3.39K.
  • Harbour Investments first reported a position in Senti Biosciences Holdings in Q4 2022 and held it in 7 quarters.
  • Harbour Investments's Senti Biosciences Holdings position peaked at $9.9K in Q4 2023.
  • 16 funds tracked by Wall St. Rank held Senti Biosciences Holdings as of Q4 2024.

Based on Harbour Investments's 13F filing for Q4 2024, filed 10 Feb 2025.